Suppr超能文献

通过对三甲基胺尿症进行表型分析在日本人群中鉴定出黄素单加氧酶 3(FMO3)的遗传变异,并在基因组资源数据库中发现。

Genetic variants of flavin-containing monooxygenase 3 (FMO3) in Japanese subjects identified by phenotyping for trimethylaminuria and found in a database of genome resources.

机构信息

Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Tokyo, Japan.

Advanced Research Center for Innovations in Next-Generation Medicine, Tohoku University, Sendai, Japan; Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.

出版信息

Drug Metab Pharmacokinet. 2021 Jun;38:100387. doi: 10.1016/j.dmpk.2021.100387. Epub 2021 Feb 25.

Abstract

The oxygenation of food-derived trimethylamine to its N-oxide is a representative reaction mediated by human flavin-containing monooxygenase 3 (FMO3). Impaired FMO3 enzymatic activity is associated with trimethylaminuria (accumulation of substrate), whereas trimethylamine N-oxide (metabolite) is associated with arteriosclerosis. We previously reported FMO3 single-nucleotide and/or haplotype variants with low FMO3 metabolic capacity using urinary phenotyping and the whole-genome sequencing of Japanese populations. Here, we further analyze Japanese volunteers with self-reported malodor and interrogate an updated Japanese database for novel FMO3 single-nucleotide and/or haplotype variants. After 3 years of follow up, seven probands were found to harbor the known impaired FMO3 variant p.(Gly191Cys) identified in the database or novel variants/haplotypes including p.(Met66Val), p.(Arg223Gln), p.(Glu158Lys;Glu308Gly;Arg492Trp), and p.(Glu158Lys;Glu308Gly;Pro496Ser). The known severe mutation p.(Cys197Ter) (a TG deletion) and four variants including p.(Tyr269His) and p.(Pro496Ser) were first detected in the updated genome panel. Among previously unanalyzed FMO3 variants, the trimethylamine/benzydamine N-oxygenation activities of recombinant p.(Met66Val), p.(Arg223Gln), p.(Tyr269His), p.(Glu158Lys;Glu308Gly;Arg492Trp), and p.(Glu158Lys;Glu308Gly;Pro496Ser) FMO3 variant proteins were severely decreased (V/K <10% of wild-type). Although the present novel mutations or alleles were relatively rare, both in self-reported Japanese trimethylaminuria sufferers and in the genomic database panel, three common FMO3 missense or deletion variants severely impaired FMO3-mediated N-oxygenation of trimethylamine.

摘要

食物源性三甲基胺转化为其 N-氧化物是由人黄素单加氧酶 3(FMO3)介导的代表性反应。FMO3 酶活性受损与三甲基氨尿症(底物积累)有关,而三甲基胺 N-氧化物(代谢物)与动脉粥样硬化有关。我们之前使用尿表型和全基因组测序报告了日本人群中 FMO3 单核苷酸和/或单倍型变异与低 FMO3 代谢能力相关。在这里,我们进一步分析了自我报告有异味的日本志愿者,并对更新的日本数据库进行了新的 FMO3 单核苷酸和/或单倍型变异的询问。经过 3 年的随访,发现 7 名先证者携带数据库中鉴定的已知 FMO3 变异 p.(Gly191Cys)或新的变异/单倍型,包括 p.(Met66Val)、p.(Arg223Gln)、p.(Glu158Lys;Glu308Gly;Arg492Trp)和 p.(Glu158Lys;Glu308Gly;Pro496Ser)。已知严重突变 p.(Cys197Ter)(TG 缺失)和包括 p.(Tyr269His)和 p.(Pro496Ser)在内的四个变异首先在更新的基因组面板中被检测到。在以前未分析的 FMO3 变异中,重组 p.(Met66Val)、p.(Arg223Gln)、p.(Tyr269His)、p.(Glu158Lys;Glu308Gly;Arg492Trp)和 p.(Glu158Lys;Glu308Gly;Pro496Ser) FMO3 变异蛋白的三甲基胺/苯佐卡因 N-氧化活性严重降低(V/K<野生型的 10%)。虽然目前的新突变或等位基因相对较少,无论是在自我报告的日本三甲基氨尿症患者还是在基因组数据库面板中,三个常见的 FMO3 错义或缺失变异都严重损害了 FMO3 介导的三甲基胺 N-氧化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验